taurine has been researched along with Cognitive Decline in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objectives of this study were to investigate whether taurine (Tau) can prevent d-galactose-induced cognitive dysfunction and brain oxidative damage." | 7.88 | Preventive effects of taurine against d-galactose-induced cognitive dysfunction and brain damage. ( Chang, YL; Chang, YY; Chen, YC; Chiang, CC; Chou, CH; Lin, YL; Tu, DG, 2018) |
| " Chronic administration of taurine attenuated STZ-induced cognitive impairment." | 5.46 | Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. ( Gupta, YK; Reeta, KH; Singh, D, 2017) |
| " The objectives of this study were to investigate whether taurine (Tau) can prevent d-galactose-induced cognitive dysfunction and brain oxidative damage." | 3.88 | Preventive effects of taurine against d-galactose-induced cognitive dysfunction and brain damage. ( Chang, YL; Chang, YY; Chen, YC; Chiang, CC; Chou, CH; Lin, YL; Tu, DG, 2018) |
| "Taurine is an inhibitory neuromodulatory amino acid in the central nervous system that activates the GABA- and glycine-insensitive chloride channel and inhibits the N-methyl-D-aspartate receptor." | 2.82 | Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study. ( Allott, KA; McGorry, PD; Moral, J; Murphy, BP; O'Donnell, CP; O'Regan, MK; Papas, A; Pham, T; Phassouliotis, C; Proffitt, TM; Simpson, R; Yuen, HP, 2016) |
| "Taurine is a key functional amino acid with many functions in the nervous system." | 2.61 | Roles of taurine in cognitive function of physiology, pathologies and toxication. ( Chen, C; Han, H; He, J; Lu, G; Xia, S; Xie, Z, 2019) |
| "Homotaurine is a potential therapeutic compound for treatment of Alzheimer's disease (AD), but its efficacy is still under investigation." | 1.72 | IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment. ( Banaj, N; Bossù, P; Golesorkhtafti, S; Lembo, M; Messina, B; Sireno, L; Spalletta, G; Toppi, E, 2022) |
| "We assessed the protective effect on a carotid artery stenosis rat model with using a combination of taurine and stenosis treatment." | 1.46 | Efficacy of a combination of taurine and stenosis removing on cognitive impairment induced by carotid artery stenosis in rats. ( Liu, XZ; Wang, FC; Wang, Y; Zhang, JX, 2017) |
| " Chronic administration of taurine attenuated STZ-induced cognitive impairment." | 1.46 | Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. ( Gupta, YK; Reeta, KH; Singh, D, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toppi, E | 1 |
| Sireno, L | 1 |
| Lembo, M | 1 |
| Banaj, N | 1 |
| Messina, B | 1 |
| Golesorkhtafti, S | 1 |
| Spalletta, G | 2 |
| Bossù, P | 1 |
| Bae, MA | 1 |
| Lee, ES | 1 |
| Cho, SM | 1 |
| Kim, SH | 1 |
| Chang, KJ | 1 |
| Wang, J | 1 |
| Niu, Y | 1 |
| Tao, H | 1 |
| Xue, M | 1 |
| Wan, C | 1 |
| Liu, XZ | 1 |
| Wang, FC | 1 |
| Wang, Y | 1 |
| Zhang, JX | 1 |
| Tu, DG | 1 |
| Chang, YL | 1 |
| Chou, CH | 1 |
| Lin, YL | 1 |
| Chiang, CC | 1 |
| Chang, YY | 1 |
| Chen, YC | 1 |
| Wolfrum, C | 1 |
| Peleg-Raibstein, D | 1 |
| Chen, C | 1 |
| Xia, S | 1 |
| He, J | 1 |
| Lu, G | 1 |
| Xie, Z | 1 |
| Han, H | 1 |
| Cassol, G | 1 |
| Godinho, DB | 1 |
| de Zorzi, VN | 1 |
| Farinha, JB | 1 |
| Della-Pace, ID | 1 |
| de Carvalho Gonçalves, M | 1 |
| Oliveira, MS | 1 |
| Furian, AF | 1 |
| Fighera, MR | 1 |
| Royes, LFF | 1 |
| Cravello, L | 1 |
| Gianni, W | 1 |
| Piras, F | 2 |
| Iorio, M | 1 |
| Cacciari, C | 1 |
| Casini, AR | 1 |
| Chiapponi, C | 1 |
| Sancesario, G | 1 |
| Fratangeli, C | 1 |
| Orfei, MD | 1 |
| Caltagirone, C | 1 |
| Koob, M | 1 |
| Viola, A | 1 |
| Le Fur, Y | 1 |
| Viout, P | 1 |
| Ratiney, H | 1 |
| Confort-Gouny, S | 1 |
| Cozzone, PJ | 1 |
| Girard, N | 1 |
| O'Donnell, CP | 1 |
| Allott, KA | 1 |
| Murphy, BP | 1 |
| Yuen, HP | 1 |
| Proffitt, TM | 1 |
| Papas, A | 1 |
| Moral, J | 1 |
| Pham, T | 1 |
| O'Regan, MK | 1 |
| Phassouliotis, C | 1 |
| Simpson, R | 1 |
| McGorry, PD | 1 |
| Reeta, KH | 1 |
| Singh, D | 1 |
| Gupta, YK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A 12-week, Parallel, Double-blind, Randomised, Placebo-controlled Adjunctive Study of Taurine 4 Grams in 128 Patients With First-episode Psychosis Receiving Antipsychotic Treatment.[NCT00420823] | Phase 2/Phase 3 | 121 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for taurine and Cognitive Decline
| Article | Year |
|---|---|
Roles of taurine in cognitive function of physiology, pathologies and toxication.
Topics: Alzheimer Disease; Animals; Antioxidants; Cognition; Cognitive Dysfunction; Dietary Supplements; Fem | 2019 |
Potential therapeutic implications of ergogenic compounds on pathophysiology induced by traumatic brain injury: A narrative review.
Topics: Animals; Arginine; Brain Injuries, Traumatic; Caffeine; Carnitine; Central Nervous System Stimulants | 2019 |
1 trial available for taurine and Cognitive Decline
| Article | Year |
|---|---|
Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognitive Dysfunction; Double-Blind Method; Drug Therapy, C | 2016 |
9 other studies available for taurine and Cognitive Decline
| Article | Year |
|---|---|
IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment.
Topics: Alzheimer Disease; Cognitive Dysfunction; Cytokines; Humans; Interleukin-10; Interleukin-18; Interle | 2022 |
The Effects of Dietary Taurine-Containing Jelly Supplementation on Cognitive Function and Memory Ability of the Elderly with Subjective Cognitive Decline.
Topics: Aged; Cognition; Cognitive Dysfunction; Dietary Supplements; Female; Humans; Male; Mental Status and | 2022 |
Knockdown of lncRNA TUG1 inhibits hippocampal neuronal apoptosis and participates in aerobic exercise-alleviated vascular cognitive impairment.
Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Cell Line; Cell Proliferation; Cognitive Dysf | 2020 |
Efficacy of a combination of taurine and stenosis removing on cognitive impairment induced by carotid artery stenosis in rats.
Topics: Animals; Carotid Stenosis; Catalase; Cognitive Dysfunction; Hippocampus; Male; Maze Learning; Rats; | 2017 |
Preventive effects of taurine against d-galactose-induced cognitive dysfunction and brain damage.
Topics: Animals; Brain Injuries; Cognitive Dysfunction; Galactose; Glial Fibrillary Acidic Protein; Glycatio | 2018 |
Maternal overnutrition leads to cognitive and neurochemical abnormalities in C57BL/6 mice.
Topics: Animals; Aspartic Acid; Avoidance Learning; Brain Chemistry; Cognitive Dysfunction; Diet, High-Fat; | 2019 |
Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Cognitive Dysfunction; Femal | 2016 |
Creatine, Glutamine plus Glutamate, and Macromolecules Are Decreased in the Central White Matter of Premature Neonates around Term.
Topics: Cognitive Dysfunction; Creatine; Diffusion Magnetic Resonance Imaging; Female; Glutamic Acid; Glutam | 2016 |
Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation.
Topics: Animals; Choline O-Acetyltransferase; Cognitive Dysfunction; Drug Administration Schedule; Inflammat | 2017 |